SEC Comment Letter for NOVARTIS AG (NVS, NVSEF) (CIK 0001114448) (NVS) — Aug 14, 2012
NOVARTIS AG (NVS, NVSEF) (CIK 0001114448)
Date: Aug. 14, 2012 · CIK: 0001114448 · Accession: 0000000000-12-044029
AI Filing Summary & Sentiment
File numbers found in text: 001-15024
Show Raw Text
August 14 , 201 2 Via E -mail Mr. Jonathan Symonds Chief Financial Officer Novartis AG Lichtstrasse 35 4056 Basel, Switzerland Re: Novartis AG Form 20-F for the Fiscal Year Ended December 31 , 2011 Filed January 25, 201 2 File No. 001-15024 Dear M r. Symonds : We have completed our review of your filing. We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require. Sincerely, /s/ Gus Rodriguez Gus Rodriguez Accounting Branch Ch ief